Christopher Patusky - 09 Nov 2026 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Nov 2026, 16:34:03 UTC
Prior SEC filing
23 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John S. Hess, Jr. under Power of Attorney
Filing notes and source

Key filing fact

Christopher Patusky filed Form 4 for UNITED THERAPEUTICS Corp (UTHR) on 10 Nov 2026.

Key facts

  • This page summarizes Christopher Patusky's Form 4 filing for UNITED THERAPEUTICS Corp (UTHR).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 10 Nov 2026, 16:34.

Change

  • Previous filing in this sequence was filed on 23 Jul 2026.
  • Current net transaction value: -$701,800.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001231427 Primary reporting owner

PATUSKY CHRISTOPHER

Relationship
Director
Address
C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Signature date
10 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

UTHR transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,210
Change %
+57%
Price
$132.30*
Shares after
3,350
Date
09 Nov 2026
Ownership
Direct
Footnotes
F1
UTHR transaction

Common Stock

Sale

Transaction value
-$701,800
Shares
-1,210
Change %
-36%
Price
$580.00
Shares after
2,140
Date
09 Nov 2026
Ownership
Direct
UTHR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,100
Date
09 Nov 2026
Ownership
by Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

UTHR transaction Derivative

Stock Option

Options Exercise

Transaction value
Shares
-1,210
Change %
-29%
Price
$0.000000*
Shares after
3,000
Date
09 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,210
Exercise price
$132.30
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Form 4 filed by the Reporting Person on July 23, 2026 incorrectly reported the Amount of Securities Beneficially Owned following Reported Transaction in Column 5 of Table I. The correct number should have been 2,140.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .